Osteopontin promotes pathologic mineralization in articular cartilage.
about
Characterization of articular calcium-containing crystals by synchrotron FTIRCalcium deposition in osteoarthritic meniscus and meniscal cell culture.Osterix couples chondrogenesis and osteogenesis in post-natal condylar growth.Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development.Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cellsPhosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition.Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.Pathophysiology of articular chondrocalcinosis--role of ANKH.The Therapeutic Potential of Exogenous Adenosine Triphosphate (ATP) for Cartilage Tissue Engineering.Fibroblast-like synoviocytes induce calcium mineral formation and depositionQuantitative genetic study of the circulating osteopontin in community-selected families.Parallel regulation of extracellular ATP and inorganic pyrophosphate: roles of growth factors, transduction modulators, and ANK.Long noncoding RNAs: a new regulatory code in osteoarthritis.The development of collagen based composite scaffolds for bone regeneration.
P2860
Q33333783-BF823139-3DFC-4A1F-BC60-4DA85AC18838Q33923370-D663B1AF-9436-4F3E-85FE-B646E4DAE587Q34417961-6DD4CAD5-AD17-4E94-A20C-F6540786E381Q34605944-73EE9102-E689-4363-9747-DD73BAA80381Q35722323-0371BB99-2B1E-4943-8BF3-AEB05B7FB99DQ36959741-659FE729-8592-4540-B7EE-AAA34932CDC7Q37093030-9BBE966D-80E3-4A7C-B711-0A9DAB3452C4Q37119705-2C4FD590-5C40-4349-893F-2338437C981BQ37285119-33254C9A-06C7-4BC0-8327-E71FDEF250D7Q37406648-67867CD2-E0F5-4157-9D8D-4A3D533B9489Q37811887-0D3BCDA7-C57F-45B6-A3D2-93279B97EDAAQ39545703-ADC75821-79D3-474A-BAA4-55C09092E1F2Q40623957-15D0FBA4-8CFB-4517-BB49-ECA03378880FQ46295363-FAE486EC-6C3A-43A6-8C2E-A5155E895512Q46296193-53B45D32-E5CB-4473-BCB2-F6DCF9E35AE7Q47144390-E7807A44-43A9-4777-A7D2-1D81DB7C97B0Q55314376-4FC6F8D5-76CC-4DE9-B102-8A43207B1BBC
P2860
Osteopontin promotes pathologic mineralization in articular cartilage.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Osteopontin promotes pathologic mineralization in articular cartilage.
@ast
Osteopontin promotes pathologic mineralization in articular cartilage.
@en
type
label
Osteopontin promotes pathologic mineralization in articular cartilage.
@ast
Osteopontin promotes pathologic mineralization in articular cartilage.
@en
prefLabel
Osteopontin promotes pathologic mineralization in articular cartilage.
@ast
Osteopontin promotes pathologic mineralization in articular cartilage.
@en
P2093
P2860
P1433
P1476
Osteopontin promotes pathologic mineralization in articular cartilage.
@en
P2093
Ann K Rosenthal
Claudia M Gohr
Ikuko Masuda
Miwa Uzuki
P2860
P304
P356
10.1016/J.MATBIO.2006.10.004
P577
2006-10-20T00:00:00Z